Avantor Results Presentation Deck

Q2 highlights Ongoing business momentum Core organic growth and margin expansion continue above long-term targets Strong bioproduction core growth (>20%) and robust order book - Double digit revenue growth in Advanced Technologies and Applied Materials demonstrating portfolio resilience - Executing on our growth strategy Expanded bioproduction offering with new proprietary product launches and collaboration agreements Ongoing investments in manufacturing capacity and distribution infrastructure remain on track Achieved critical integration milestones in Masterflex carveout Looking ahead Continued strength in core business offsetting accelerated COVID-19 ramp down Strong execution supporting robust margin expansion and deleveraging FX creating headwinds for revenue and adjusted EPS Navantor™ T₂ 3

View entire presentation